Pediatric primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder: A retrospective analysis and review of the literature - 17/04/25
Doi : 10.1016/j.jaad.2025.01.058
Oluwaseyi Adeuyan, BS a, Celine M. Schreidah, MD, MS a, Jeffrey W. Craig, MD, PhD b, Werner Kempf, MD c, d, Erika Morsia, MD e, Jose A. Plaza, MD f, Christina Mitteldorf, MD, PhD g, Alessandro Pileri, MD, PhD h, i, Larisa J. Geskin, MD a, j, Alejandro A. Gru, MD j, ⁎ 
a Columbia University Vagelos College of Physicians and Surgeons, New York, New York
b Department of Pathology, University of Virginia Health System, Charlottesville, Virginia
c Kempf und Pfaltz Histologische Diagnostik, Zürich, Switzerland
d Department of Dermatology, University Hospital Zürich, Zürich, Switzerland
e Hematology Clinic, Department of Clinical and Molecular Sciences (DISCLIMO), Università Politecnica delle Marche, Ancona, Italy
f Department of Pathology, The Ohio State University Wexner Medical Center, Columbus, Ohio
g Department of Dermatology, Venereology and Allergology, University Medical Center Göttingen, Göttingen, Germany
h Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico S Orsola-Malpighi, Bologna, Italy
i Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy
j Department of Dermatology, Columbia University Irving Medical Center, New York, New York
∗Correspondence to: Alejandro A. Gru, MD, Dermatopathology Section, Department of Dermatology, Columbia University Irving Medical Center, 622 W 168th St, Vanderbilt Clinic Floor 15, Room 207, New York, NY 10032Dermatopathology SectionDepartment of DermatologyColumbia University Irving Medical Center622 W 168th StVanderbilt Clinic Floor 15Room 207New YorkNY10032
Key words : atypical lymphoid infiltrate, pediatrics, primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder (PCSM-TCLPD)
| Funding sources: None. |
|
| Patient consent: Not applicable. |
|
| IRB approval status: IRB-AAAV1619, PI Gru. |
© 2025
Publié par Elsevier Masson SAS.
Vol 92 - N° 5
P. 1157-1159 - mai 2025 Retour au numéro
Article précédent
- Combination of oral minoxidil and bicalutamide for the treatment of female pattern hair loss in adolescents
- Nicole Yoong, Valerie Yii, Rodney Sinclair, Bevin Bhoyrul
- Treatment of androgenetic alopecia with low-dose oral minoxidil monotherapy compared with combination therapy with dutasteride or finasteride
- Ambika Nohria, Deesha Desai, Michelle Sikora, Akshay Pulavarty, Anna Brinks, Carli Needle, Avrom Caplan, Jerry Shapiro, Kristen Lo Sicco
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?